Navigation Links
WallSt.net Updates Investment Community Through All-New Interview With ImmuCell
Date:2/11/2008

NEW YORK, Feb. 11 /PRNewswire/ -- On February 8, Michael F. Brigham, President and CEO of ImmuCell Corporation (Nasdaq: ICCC) (http://www.immucell.com) updated the investment community in an all-new interview with http://www.wallst.net. Topics covered in the interview include an overview of the company, recent press, the market opportunity and upcoming milestones for which investors should watch.

To hear the interview in its entirety, visit http://www.wallst.net and click on "Interviews." The interview can be accessed either by locating the company's ticker symbol under the appropriate exchange at the top of the "Interviews" section of the site or by entering the company's ticker symbol in the Search Archive window.

About ImmuCell:

ImmuCell Corporation is a biotechnology company that is developing, manufacturing and selling products that improve animal health and productivity in the dairy and beef industries. Press releases and other information about the Company are available at http://www.immucell.com.

About WallSt.net:

http://www.wallst.net is owned and operated by WallStreet Direct, Inc., a wholly owned subsidiary of Financial Media Group, Inc. The Web site is a leading provider of timely business news, executive interviews, multimedia content and research tools. Financial Media Group, Inc. also owns http://www.mywallst.net, a financial social network for investors, and Financial Filings Corp., a provider of compliance solutions to publicly traded companies. Additionally, WallStreet Direct, Inc. owns and operates WallStRadio, a business and finance podcast Web site. Financial Filings Corp. is expecting to receive two hundred eighty dollars from ImmuCell Corporation for the dissemination of this press release. For a complete list of our advertising relationships, visit http://www.wallst.net/disclaimer/disclaimer.asp.

Contact: WallSt.net

800-4-WALLST


'/>"/>
SOURCE WallStreet Direct, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. WallSt.net Announces Upcoming Interview With CEO of ReBuilder Medical Technologies
2. WallSt.net Announces Upcoming Interview With CEO Of Immunosyn Corporation
3. Synvista Therapeutics to be Featured on Wallst.net
4. WallSt.net Announces Upcoming Interview With CEO of Biomoda
5. WallSt.net Announces Upcoming Interview with CEO of BioSante Pharmaceuticals
6. WallSt.net (www.wallst.net) Announces Upcoming Interview With CEO of DNAPrint Genomics
7. WallSt.net (www.wallst.net) Announces Upcoming Interview With CEO of Osteologix
8. Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook
9. Nventa updates progress of cervical dysplasia trial with new HspE7
10. SGX Pharmaceuticals Updates Date of Presentation at the BIO InvestorForum 2007
11. PAREXEL International Updates Financial Guidance in Conjunction with the Acquisition of APEX International Clinical Research Co., Ltd. and Other Factors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... Plate® YM (Yeast and Mold) microbial test has received AOAC Research Institute approval ... of microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory ...
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... NC (PRWEB) , ... June 23, 2016 , ... In ... University Hospital in Denmark detail how a patient who developed lymphedema after being treated ... tissue. The results could change the paradigm for dealing with this debilitating, frequent side ...
Breaking Biology Technology:
(Date:6/1/2016)... , June 1, 2016 ... in Election Administration and Criminal Identification to Boost Global ... a recently released TechSci Research report, " Global Biometrics ... Region, Competition Forecast and Opportunities, 2011 - 2021", the ... billion by 2021, on account of growing security concerns ...
(Date:5/20/2016)... May 20, 2016  VoiceIt is excited to ... VoicePass. By working together, VoiceIt and ... VoiceIt and VoicePass take slightly different approaches to ... both security and usability. ... this new partnership. "This marketing and ...
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
Breaking Biology News(10 mins):